# FLUAD® vs. Fluzone® High-Dose Study

> **NCT03183908** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 757 (actual)

## Conditions studied

- Pain
- Quality of Life
- Injection Site Reaction
- Side Effect of Drug
- Adverse Drug Event

## Interventions

- **BIOLOGICAL:** FLUAD®
- **BIOLOGICAL:** Fluzone® High-Dose

## Key facts

- **NCT ID:** NCT03183908
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-28
- **Primary completion:** 2019-02-14
- **Final completion:** 2019-02-14
- **Target enrollment:** 757 (ACTUAL)
- **Last updated:** 2021-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183908, "FLUAD® vs. Fluzone® High-Dose Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03183908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*